Aspirin can protect the liver from cancer

Aspirin can protect the liver from cancer

We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

How aspirin can protect our liver

If people regularly take a low dose of aspirin for an extended period of time, this is associated with a 43 percent lower risk of developing liver cancer. The drug also reduces the mortality rate for every liver disease by more than a quarter.

The recent Massachusetts General Hospital investigation found that regular low doses of aspirin can effectively protect us from liver cancer. The results of the study were published in the New England Journal of Medicine.

Aspirin to protect against fatty liver diseases and blood clots

Aspirin is already used to treat various health problems. For example, the drug is said to help treat fatty liver diseases, which are compounded by the worldwide increase in obesity. Many people are already taking aspirin as a heart medicine every day. Aspirin is a so-called platelet aggregation inhibitor. The drug thins the blood, preventing the formation of blood clots.

Can Aspirin Protect From Cancer?

The latest results suggest that aspirin can be used to fight cancer. Aspirin has been shown to protect against a variety of tumors, including intestinal tumors, tumors in the stomach and throat. However, there is still insufficient evidence to recommend aspirin to prevent cancer and death.

More than 50,000 people took part in the study

The results of the new study are based on an analysis of more than 50,000 people with chronic viral hepatitis, the most common risk factor for liver cancer. Liver cancer rates and mortality from liver disease have been rising for years and there are currently no established treatments to prevent this dangerous development.

What did aspirin take for one to three years?

The current study compared mortality rates and the number of liver cancer cases of people who took aspirin daily with people who did not take aspirin. Compared to people who took short-term aspirin daily for a period of three to twelve months, the risk of liver cancer was ten percent lower for one to three years with continuous aspirin.

Liver cancer risk reduced by up to 43 percent

If people took aspirin regularly for three to five years, the risk of liver cancer was 34 percent lower compared to people who only took the drug for a short time. Participants who used aspirin for five years or more reduced the risk by 42 percent compared to taking the medication for a short time.

Liver-related deaths decreased with aspirin

Liver-related deaths also decreased as a result of aspirin use: eleven percent of people taking aspirin died from liver disease compared to 18 percent of people who did not take the drug. (as)

Author and source information

This text corresponds to the requirements of the medical literature, medical guidelines and current studies and has been checked by medical doctors.


  • Tracey G. Simon, M.D., M.P.H., Ann-Sofi Duberg, M.D., Ph.D., Soo Aleman, M.D., Ph.D., Raymond T. Chung, M.D., Andrew T. Chan, M.D., M.P.H. et al .: Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality, in New England Journal of Medicine (Published 3/12/2020), New England Journal of Medicine

Video: Strategies to Reduce the Risk of Cancer Recurrence (February 2023).